Publications
56 publications
Funding
3 grantsView NIH portfolio on RePORTER ↗
Active
2 grants- MPIP50CA257881-05Recombinant Interleukin-33 Immunotherapy for Pancreatic CancerNCI · 2022–2027 · via NIH RePORTER
- MPIR01CA262516-04Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer ImmunityNCI · 2022–2027 · via NIH RePORTER
Completed grants (1)
- MPIU01CA224175-03Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapyNCI · 2017–2022 · via NIH RePORTER